Filing Details
- Accession Number:
- 0001140361-18-013317
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-13 17:57:35
- Reporting Period:
- 2018-03-09
- Accepted Time:
- 2018-03-13 17:57:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1514588 | Adam Havey | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Evp, Business Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-03-09 | 974 | $51.84 | 35,756 | No | 4 | F | Direct | |
Common Stock | Disposition | 2018-03-12 | 5,842 | $52.82 | 29,914 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.50 to $53.16, inclusive.